Position in TCRX
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$24,819
+$245 QoQ
Shares Held
24,574
0.0% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TCRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HSBC HOLDINGS PLC holds $964,242,571 across 122 Biotechnology names. TCRX ranks #118 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
655,443 | $292,681,510 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
323,338 | $249,823,869 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,544,018 | $74,066,541 | |
| 4 | INCY |
Incyte Corp
|
582,368 | $54,812,474 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
89,619 | $29,652,235 | |
| 6 | MRNA |
Moderna, Inc.
|
490,088 | $24,896,468 | |
| 7 | INSM |
INSMED Inc
|
116,456 | $19,042,883 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
227,059 | $15,469,528 |
All Filings in TCRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,819 | 24,574 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $24,574 | 24,574 | Shares | Defined | 2026-03-20 | |
| 2025-09-30 | $44,724 | 24,574 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $44,226 | 30,501 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $48,357 | 35,042 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||